Cargando…

From Eye Drops to ICU, a Case Report of Three Side Effects of Ophthalmic Timolol Maleate in the Same Patient

Timolol Maleate (also called Timolol) is a nonselective beta-adrenergic blocker and a class II antiarrhythmic drug, which is used to treat intraocular hypertension. It has been reported to cause systemic side effects especially in elderly patients with other comorbidities. These side effects are due...

Descripción completa

Detalles Bibliográficos
Autores principales: Rana, Muhammad Asim, Mady, Ahmed Fouad, Rehman, Basheer Abdel, Alharthy, Abdulrahman, Huwait, Basim, Riaz, Asim, Aletreby, Waleed Tharwat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4545277/
https://www.ncbi.nlm.nih.gov/pubmed/26347135
http://dx.doi.org/10.1155/2015/714919
_version_ 1782386738680823808
author Rana, Muhammad Asim
Mady, Ahmed Fouad
Rehman, Basheer Abdel
Alharthy, Abdulrahman
Huwait, Basim
Riaz, Asim
Aletreby, Waleed Tharwat
author_facet Rana, Muhammad Asim
Mady, Ahmed Fouad
Rehman, Basheer Abdel
Alharthy, Abdulrahman
Huwait, Basim
Riaz, Asim
Aletreby, Waleed Tharwat
author_sort Rana, Muhammad Asim
collection PubMed
description Timolol Maleate (also called Timolol) is a nonselective beta-adrenergic blocker and a class II antiarrhythmic drug, which is used to treat intraocular hypertension. It has been reported to cause systemic side effects especially in elderly patients with other comorbidities. These side effects are due to systemic absorption of the drug and it is known that Timolol is measurable in the serum following ophthalmic use. Chances of life threatening side effects increase if these are coprescribed with other cardiodepressant drugs like calcium channel or systemic beta blockers. We report a case where an elderly patient was admitted with three side effects of Timolol and his condition required ICU admission with mechanical ventilation and temporary transvenous pacing. The case emphasizes the need of raising awareness among physicians of such medications about the potential side effects and drug interactions. A close liaison among patient's physicians is suggested.
format Online
Article
Text
id pubmed-4545277
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-45452772015-09-06 From Eye Drops to ICU, a Case Report of Three Side Effects of Ophthalmic Timolol Maleate in the Same Patient Rana, Muhammad Asim Mady, Ahmed Fouad Rehman, Basheer Abdel Alharthy, Abdulrahman Huwait, Basim Riaz, Asim Aletreby, Waleed Tharwat Case Rep Crit Care Case Report Timolol Maleate (also called Timolol) is a nonselective beta-adrenergic blocker and a class II antiarrhythmic drug, which is used to treat intraocular hypertension. It has been reported to cause systemic side effects especially in elderly patients with other comorbidities. These side effects are due to systemic absorption of the drug and it is known that Timolol is measurable in the serum following ophthalmic use. Chances of life threatening side effects increase if these are coprescribed with other cardiodepressant drugs like calcium channel or systemic beta blockers. We report a case where an elderly patient was admitted with three side effects of Timolol and his condition required ICU admission with mechanical ventilation and temporary transvenous pacing. The case emphasizes the need of raising awareness among physicians of such medications about the potential side effects and drug interactions. A close liaison among patient's physicians is suggested. Hindawi Publishing Corporation 2015 2015-08-06 /pmc/articles/PMC4545277/ /pubmed/26347135 http://dx.doi.org/10.1155/2015/714919 Text en Copyright © 2015 Muhammad Asim Rana et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Rana, Muhammad Asim
Mady, Ahmed Fouad
Rehman, Basheer Abdel
Alharthy, Abdulrahman
Huwait, Basim
Riaz, Asim
Aletreby, Waleed Tharwat
From Eye Drops to ICU, a Case Report of Three Side Effects of Ophthalmic Timolol Maleate in the Same Patient
title From Eye Drops to ICU, a Case Report of Three Side Effects of Ophthalmic Timolol Maleate in the Same Patient
title_full From Eye Drops to ICU, a Case Report of Three Side Effects of Ophthalmic Timolol Maleate in the Same Patient
title_fullStr From Eye Drops to ICU, a Case Report of Three Side Effects of Ophthalmic Timolol Maleate in the Same Patient
title_full_unstemmed From Eye Drops to ICU, a Case Report of Three Side Effects of Ophthalmic Timolol Maleate in the Same Patient
title_short From Eye Drops to ICU, a Case Report of Three Side Effects of Ophthalmic Timolol Maleate in the Same Patient
title_sort from eye drops to icu, a case report of three side effects of ophthalmic timolol maleate in the same patient
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4545277/
https://www.ncbi.nlm.nih.gov/pubmed/26347135
http://dx.doi.org/10.1155/2015/714919
work_keys_str_mv AT ranamuhammadasim fromeyedropstoicuacasereportofthreesideeffectsofophthalmictimololmaleateinthesamepatient
AT madyahmedfouad fromeyedropstoicuacasereportofthreesideeffectsofophthalmictimololmaleateinthesamepatient
AT rehmanbasheerabdel fromeyedropstoicuacasereportofthreesideeffectsofophthalmictimololmaleateinthesamepatient
AT alharthyabdulrahman fromeyedropstoicuacasereportofthreesideeffectsofophthalmictimololmaleateinthesamepatient
AT huwaitbasim fromeyedropstoicuacasereportofthreesideeffectsofophthalmictimololmaleateinthesamepatient
AT riazasim fromeyedropstoicuacasereportofthreesideeffectsofophthalmictimololmaleateinthesamepatient
AT aletrebywaleedtharwat fromeyedropstoicuacasereportofthreesideeffectsofophthalmictimololmaleateinthesamepatient